tunnel view in white building

22 July 20262 minute read

DLA Piper shortlisted for the 2026 LMG Life Sciences Americas Awards

DLA Piper is pleased to announce the firm has been shortlisted for the 2026 Legal Media Group (LMG) Life Sciences Americas Awards in the following categories:

In addition, the following DLA Piper lawyers have been shortlisted for individual honors:

  • Loren BrownProduct Liability Attorney of the Year
  • Lisa HailePatent Strategy Attorney of the Year – California
  • Ray MillerPatent Attorney of the Year – Pennsylvania
  • Vernessa PollardRegulatory Attorney of the Year: FDA Medical Device
  • Rebecca von RutiProduct Liability Attorney of the Year – Canada

The firm was also shortlisted in the following categories:

  • Mid-Market Transactions Firm of the Year
  • Product Liability Firm of the Year
  • Product Liability Firm of the Year – Canada
  • Life Cycle Firm of the Year (Special Awards) – Canada

We congratulate our shortlisted lawyers and teams on this recognition and are honored to be acknowledged for our continued work on behalf of clients across the life sciences sector.

The winners will be announced at a gala celebration on September 10, 2026, at Guastavino's in New York City.

DLA Piper's globally recognized life sciences team has spent decades helping entrepreneurs, companies, innovators, and investors turn their most promising and disruptive ideas into successful businesses. Drawing on diverse backgrounds in the legal, financial, medical, and scientific sectors, our team brings a distinctive blend of experience to develop client-focused solutions. We understand the unique challenges life sciences companies face in securing funding, licensing and protecting intellectual property, establishing strategic partnerships, bringing new products to market, navigating complex regulatory frameworks, opening new paths to profitability, and protecting existing innovation. Our approach delivers both strategic and practical counsel to clients, ultimately leading to better business and human outcomes.